Which of the following populations is NOT listed as a group in which the SGA has been found to predict complications?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

Which of the following populations is NOT listed as a group in which the SGA has been found to predict complications?

Explanation:
The concept being tested is how widely the Subjective Global Assessment (SGA) has been shown to predict complications across different patient groups. In adults, SGA has been repeatedly associated with postoperative complications and other outcomes in several populations: those undergoing gastrointestinal surgery, patients undergoing liver transplantation, and individuals on dialysis. Malnutrition indicated by SGA in these groups correlates with higher infection risk, longer hospital stays, more complications, and even mortality, which is why these groups are commonly cited as having predictive value with the SGA. In pediatric oncology, the evidence is less robust and the SGA is not as consistently validated as a predictor of complications. Pediatric and cancer-specific nutrition assessments often rely on tools tailored to children, and the SGA is not as widely established in this population. Because of this, pediatric oncology is not typically listed as a group with proven predictive value of the SGA for complications, making it the best choice for the option that isn’t supported by strong, widely cited evidence. So, the correct interpretation is that while the SGA has demonstrated predictive ability in the adult groups listed, pediatric oncology does not have the same level of validated evidence.

The concept being tested is how widely the Subjective Global Assessment (SGA) has been shown to predict complications across different patient groups. In adults, SGA has been repeatedly associated with postoperative complications and other outcomes in several populations: those undergoing gastrointestinal surgery, patients undergoing liver transplantation, and individuals on dialysis. Malnutrition indicated by SGA in these groups correlates with higher infection risk, longer hospital stays, more complications, and even mortality, which is why these groups are commonly cited as having predictive value with the SGA.

In pediatric oncology, the evidence is less robust and the SGA is not as consistently validated as a predictor of complications. Pediatric and cancer-specific nutrition assessments often rely on tools tailored to children, and the SGA is not as widely established in this population. Because of this, pediatric oncology is not typically listed as a group with proven predictive value of the SGA for complications, making it the best choice for the option that isn’t supported by strong, widely cited evidence.

So, the correct interpretation is that while the SGA has demonstrated predictive ability in the adult groups listed, pediatric oncology does not have the same level of validated evidence.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy